mifepristone has been researched along with Glucose Intolerance in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (14.29) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 5 (71.43) | 24.3611 |
2020's | 1 (14.29) | 2.80 |
Authors | Studies |
---|---|
Grewal, S; Gubbi, S; McGlotten, R; Muniyappa, R; Nieman, LK; Sharma, ST | 1 |
Berki, T; Nikolic, I; Saksida, T; Stojanovic, I; Stosic-Grujicic, S; Vujicic, M | 1 |
Braunstein, GD; Feldman, D; Gross, C; Katznelson, L; Loriaux, DL; Schteingart, DE | 1 |
Ito, S; Matsuura, N; Murohara, T; Nagasawa, K; Nagata, K; Sano, Y; Takeshita, Y; Uchinaka, A; Yamada, Y | 1 |
Beaudry, JL; Belanoff, JK; Dunford, EC; Hunt, H; Pivovarov, JA; Porras, DP; Riddell, MC; Teich, T | 1 |
Biller, BM; Findling, JW; Fleseriu, M; Gross, C; Molitch, ME; Schteingart, DE | 1 |
Baer, DJ; Castonguay, TW; Trocki, O | 1 |
3 trial(s) available for mifepristone and Glucose Intolerance
Article | Year |
---|---|
Mifepristone Improves Adipose Tissue Insulin Sensitivity in Insulin Resistant Individuals.
Topics: Adipose Tissue; Adult; Aged; Cross-Over Studies; Double-Blind Method; Female; Glucose Intolerance; Humans; Insulin Resistance; Insulin Secretion; Male; Middle Aged; Mifepristone; Obesity; Overweight; Prediabetic State; United States | 2021 |
Global clinical response in Cushing's syndrome patients treated with mifepristone.
Topics: Adult; Aged; Blood Pressure; Cushing Syndrome; Diabetes Mellitus, Type 2; Female; Glucose Intolerance; Hormone Antagonists; Humans; Hypertension; Male; Middle Aged; Mifepristone; Quality of Life; Receptors, Glucocorticoid | 2014 |
Mifepristone, a glucocorticoid receptor antagonist, produces clinical and metabolic benefits in patients with Cushing's syndrome.
Topics: Adult; Antihypertensive Agents; Blood Glucose; Blood Pressure; Body Composition; Body Weight; Cushing Syndrome; Diabetes Mellitus, Type 2; Female; Glucose Intolerance; Hormone Antagonists; Humans; Hydrocortisone; Hypertension; Male; Middle Aged; Mifepristone; Quality of Life; Quinolines; Receptors, Glucocorticoid; Urea | 2012 |
4 other study(ies) available for mifepristone and Glucose Intolerance
Article | Year |
---|---|
The role of endogenous glucocorticoids in glucose metabolism and immune status of MIF-deficient mice.
Topics: Animals; Corticosterone; Gene Knockout Techniques; Glucocorticoids; Glucose; Glucose Intolerance; Immunity; Macrophage Migration-Inhibitory Factors; Male; Mice; Mice, Inbred C57BL; Mifepristone; Receptors, Glucocorticoid | 2013 |
Attenuation of cold stress-induced exacerbation of cardiac and adipose tissue pathology and metabolic disorders in a rat model of metabolic syndrome by the glucocorticoid receptor antagonist RU486.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; Adipose Tissue; Animals; Cold Temperature; Disease Models, Animal; Fibrosis; Glucose Intolerance; Heart; Hypertrophy, Left Ventricular; Male; Metabolic Syndrome; Mifepristone; Rats; Rats, Inbred Dahl; Rats, Zucker; Receptors, Glucocorticoid; Receptors, Leptin; Stress, Physiological | 2016 |
Glucocorticoid antagonism limits adiposity rebound and glucose intolerance in young male rats following the cessation of daily exercise and caloric restriction.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; Adiposity; Animals; Blood Glucose; Blotting, Western; Body Weight; Caloric Restriction; Gluconeogenesis; Glucose Intolerance; Glucose Tolerance Test; Glycogen; Glycogenolysis; Hormone Antagonists; Insulin; Insulin Resistance; Intra-Abdominal Fat; Lipolysis; Liver; Male; Mifepristone; Physical Conditioning, Animal; Rats; Rats, Sprague-Dawley; Receptors, Glucocorticoid | 2016 |
Comparison of effects of adrenalectomy and RU-486 in rats given a choice of maintenance diet and fat supplement.
Topics: Adrenalectomy; Animals; Body Composition; Body Weight; Corticosterone; Diet; Dietary Fats; Eating; Energy Intake; Food Preferences; Glucose Intolerance; Insulin; Male; Mifepristone; Rats; Rats, Sprague-Dawley; Receptors, Glucocorticoid; Triglycerides | 1995 |